H.C. Wainwright & Co. Is Once Again Ranked #1 by …
NEW YORK, February 02, 2024 -- (BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during 2023, having executed 147 transactions – more than double...
H.C. Wainwright & Co. Is Once Again Ranked #1 by …
Oct 29, 2024 · H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during the third quarter of 2024, maintaining the Firm’s top position for 38 consecutive quarters, in...
News – H.C. Wainwright & Co. - hcwco.com
Jul. 8, 2015 – H.C. Wainwright & Co. Ranked #1 Placement Agent for the First Half of 2015 by Sagient Research Systems; May 15, 2015 – H.C. Wainwright to Initiate Equity Research Coverage in Clean and Emerging Technologies; Feb. 9, 2015 – H.C. Wainwright Adds Fifth Senior Analyst to Its Biotechnology Equity Research Team
H.C. Wainwright & Co. Is Once Again Ranked #1 by …
NEW YORK, May 10, 2024 -- (BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during the first quarter of 2024, maintaining the Firm’s top position...
H.C. Wainwright & Co. Is Once Again Ranked #1 by …
Jul 1, 2022 · NEW YORK-- ( BUSINESS WIRE )--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during the first half of 2022, maintaining the Firm’s top position for 29 consecutive...
Iris Energy price target raised to $16 from $13 at H.C. Wainwright
3 days ago · H.C. Wainwright raised the firm’s price target on Iris Energy (IREN) to $16 from $13 and keeps a Buy rating on the shares. The company is poised to become one of the first public miners to reach ...
CollPlant initial breast implant data ‘encouraging,’ says H.C. Wainwright
1 day ago · H.C. Wainwright maintains a Buy rating and 12-month price target of $11 on CollPlant (CLGN) shares after the company reported Q3 results and provided a corporate update on November 27. The firm ...
HC Wainwright & Co. Initiates Coverage of Sarepta Therapeutics …
Nov 21, 2024 · Fintel reports that on November 25, 2024, HC Wainwright & Co. initiated coverage of Sarepta Therapeutics (LSE:0L35) with a Sell recommendation. As of November 21, 2024, the average one-year price ...
HC Wainwright & Co. Maintains Buy Rating for Novavax: Here's …
Jan 2, 2023 · HC Wainwright & Co. has decided to maintain its Buy rating of Novavax (NASDAQ:NVAX) and lower its price target from $207.00 to $110.00. Shares of Novavax are trading up 5.76% over the last 24...
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: …
Jan 8, 2024 · HC Wainwright & Co. has decided to maintain its Buy rating of Gossamer Bio (NASDAQ:GOSS) and raise its price target from $5.00 to $10.00. Shares of Gossamer Bio are trading up 7.06% over the...